GSK vs SCSC · P/E 13, $103.31B cap vs P/E 15, rev $3.23B
GlaxoSmithKline PLC ADR (GSK) versus ScanSource Inc (SCSC) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
ScanSource Inc (SCSC) is a electronics & computer distribution company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported SCSC revenue for 2026-06-30 was $3.23B. Net income was $78.9M. Revenue was up 6.1% from 2025-06-30 to 2026-06-30. SCSC currently screens at market cap $988.6M and trailing P/E 14.8.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SCSC currently screens at market cap $988.6M and trailing P/E 14.8.
Not investment advice. Open the GSK and SCSC stock pages for the full models.
Not investment advice.